1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Prof
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office COP300
Email jamie-miller@ou.edu
Publications & Presentations
- 126. Oldham M M, Miller J L, Hagemann T M, Harrison D, Chavez-Bueno S, Johnson P N. Vancomycin dosage in overweight and obese children. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 2062-8
127. Miller J L, Hagemann T M. Use of pure opioid antagonists for management of opioid-induced pruritus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2011; 68 : 1419-25
128. Johnson P N, Miller J L, Gormley A K. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011; 31 : 609-20
129. Johnson P N, Miller J L, Boucher E A, Lubsch L, Girotto J E, Pesaturo K A, Lee B. Pediatric Pharmacy Advocacy Group Position Statement: Medication dosing in overweight and obese children. 2010
130. Gish E C, Miller J L, Gildon B, Johnson P N. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. The Annals of pharmacotherapy. 2010; 44 : 343-51
Grants
- 1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.
2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
Awards and Honors
- 16. Pediatric Pharmacy Advocacy Group. Outstanding Original Research Award. Date: 2018.
17. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2018.
18. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Department of Clinical and Administrative Sciences Teacher of the Year Award. Date: 2016.
19. Pediatric Pharmacy Advocacy Group. Christensen Memorial Young Investigator Award (Resident Mentor). Date: 2016.
20. Southwestern Oklahoma State University College of Pharmacy Alumni Association. Young Professional Achievement Award. Date: 2014.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.